Ro or LillyDirect for Zepbound? (And a Third Option Worth Knowing About)

Comparisons · 10 min read · Updated July 2026

Researched and written by the Luma Health Medical Team. Medically reviewed by Christina Bertoni, APRN.

Editorial disclosure: Luma Health is a GLP-1 telehealth provider offering compounded tirzepatide, and we compete with both paths described below. Ro and LillyDirect both sell the same FDA-approved brand medication, Zepbound — the real difference between them is structural, not clinical. We've laid out the actual math for both, plus where a compounded alternative fits into the decision.

If you've landed here, you already know you want tirzepatide specifically — probably in the form of Zepbound, Eli Lilly's FDA-approved brand product. The question isn't which medication to take; it's which pathway gets you there most affordably and reliably. Ro and LillyDirect are two of the most common routes, and they work very differently even though they end up dispensing the identical drug.

Ro Body

~$145/mo membership + $299–$499/mo medication

Ro requires an ongoing membership fee on top of the medication cost. The membership covers provider check-ins, dose adjustments, and prescription renewals. Ro can also help coordinate insurance if your plan covers Zepbound.

Online clinical evaluation and ongoing provider access
Zepbound priced separately by dose, generally $299–$499/mo
Membership roughly $39–$45 first month, then ~$145–$149/mo
Insurance coordination available for eligible patients

LillyDirect

$299–$449/mo medication only

LillyDirect is Eli Lilly's own direct-to-consumer pharmacy channel. There's no separate membership fee — you pay only for the medication itself through Lilly's Self Pay Journey Program.

No membership or platform fee
$299/mo for the 2.5 mg starting dose, $399/mo for 5 mg, $449/mo for 7.5–15 mg
Requires completing your refill within a 45-day window to keep the discounted price
Available as single-dose vial or KwikPen; Walmart pickup available in some areas

The actual cost math

Because Ro layers a membership fee on top of the medication price, the effective monthly cost of getting Zepbound through Ro runs meaningfully higher than getting the same drug through LillyDirect directly — for the same dose.

Dose tier	Ro Body (membership + med)	LillyDirect (med only)	Luma Health (compounded)
Starting dose	~$444/mo	$299/mo	$297/mo flat
Mid dose	~$544/mo	$399/mo	$297/mo flat
Higher doses (7.5–15 mg)	~$594–$648/mo	$449/mo	$297/mo flat

Ro and LillyDirect figures reflect publicly available pricing as of mid-2026 and can change — always verify current pricing directly with each provider before enrolling. Luma Health figures are compounded tirzepatide, not brand-name Zepbound; see the note below on what that distinction means.

Between Ro and LillyDirect specifically: if all you want is the brand product at the lowest price, LillyDirect's direct-to-consumer pricing beats Ro's membership-plus-medication structure at every dose tier we could verify. Ro's advantage is the added clinical support layer and insurance-coordination help, which may be worth the membership fee if you have a plan that might cover part of the cost, or if you specifically want ongoing check-ins bundled in. LillyDirect is the leaner, cheaper path if you're paying fully out of pocket and don't need that extra layer.

An important distinction: compounded vs. brand-name

Luma Health's $297/mo price is for compounded tirzepatide — the same active ingredient as Zepbound, prepared per individual prescription by VialsRX, a 503A community sterile compounding pharmacy licensed by the Texas State Board of Pharmacy (#35264). It is not the FDA-approved Zepbound product itself. Following the FDA's 2025 determination that the tirzepatide shortage had resolved, mass compounding of tirzepatide as a direct copy of Zepbound is no longer broadly permitted; 503A compounding remains a legal pathway under state board oversight, generally intended for individualized patient circumstances rather than as a blanket substitute. If having the FDA-approved brand product specifically matters to you — for insurance documentation, for example, or personal preference — that points toward Ro or LillyDirect. If your priority is accessing the same active ingredient at the lowest verified cost, compounded tirzepatide through a named, licensed pharmacy is the more affordable route.

The clinical evidence behind tirzepatide

Whichever pathway you choose, the active ingredient's efficacy data doesn't change. SURMOUNT-1 showed substantial weight reduction in adults with obesity at higher doses (Jastreboff et al., NEJM 2022), and in a head-to-head trial against semaglutide in patients with type 2 diabetes, tirzepatide produced greater weight loss at its highest dose (Frías et al., NEJM 2021, SURPASS-2). Tirzepatide has also demonstrated meaningful improvement in obstructive sleep apnea severity (Malhotra et al., NEJM 2024, SURMOUNT-OSA).

Who each path fits best

LillyDirect fits best if you:

Specifically want the FDA-approved brand product
Are paying entirely out of pocket with no insurance involvement
Can reliably complete refills within the 45-day window

Ro fits best if you:

Want ongoing clinical check-ins bundled into your plan
Have insurance that might partially cover Zepbound and want help coordinating it
Prefer a single provider relationship over a manufacturer-direct channel

Luma Health fits best if you:

Want the lowest verified monthly cost for the same active ingredient
Want one flat rate that doesn't change as your prescribed dose increases
Want a named, state-licensed compounding pharmacy you can verify before paying
Don't have a specific requirement for the FDA-approved brand product itself

Frequently Asked Questions

Is Ro or LillyDirect cheaper for Zepbound?

At every dose tier we could verify, LillyDirect's direct-to-consumer pricing runs lower than Ro's total cost, because Ro adds an ongoing membership fee (roughly $145/mo) on top of the medication price, while LillyDirect charges only for the medication itself.

Does Ro offer compounded tirzepatide?

Ro's current public program emphasizes FDA-approved brand-name medications, including Zepbound, rather than compounded tirzepatide. If a lower-cost compounded option is what you're looking for, that's typically found through a different provider.

What happens if I miss the LillyDirect 45-day refill window?

If you don't complete your refill within 45 days of your previous delivery, you lose the discounted Self Pay Journey Program pricing for that refill and pay the standard, higher self-pay rate instead. You can typically re-enroll at the discounted rate with your next order.

Is compounded tirzepatide the same as Zepbound?

Compounded tirzepatide contains the same active pharmaceutical ingredient as Zepbound, but it is prepared per individual prescription by a state-licensed compounding pharmacy rather than manufactured and FDA-approved as a finished drug product. The active ingredient's clinical trial evidence applies either way, but the preparation itself carries a different regulatory status.

Can I use insurance with LillyDirect?

No — LillyDirect's Self Pay Journey Program pricing is a cash-pay program and cannot be combined with insurance billing. If you have commercial insurance that covers Zepbound, a manufacturer savings card used at a retail pharmacy may bring your cost down further than LillyDirect's cash price.

Why does Luma Health cost less than Ro or LillyDirect for the same active ingredient?

Luma Health's price reflects compounded tirzepatide prepared by a 503A pharmacy, which is generally less expensive to produce than an FDA-approved, manufacturer-branded product with its associated regulatory and production costs. This is a structural pricing difference, not a discount or promotional rate.

Is it legal to get compounded tirzepatide in 2026?

503A compounding pharmacies can still legally prepare tirzepatide under state pharmacy board oversight, generally for individualized patient circumstances rather than as a mass-produced substitute for Zepbound now that the FDA has determined the shortage is resolved. Ask any provider directly about the basis for your specific prescription.

References

Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387:205-216. PubMed
Frías JP, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). N Engl J Med. 2021;385:503-515. PubMed
Malhotra A, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA). N Engl J Med. 2024;391. PubMed
Eli Lilly and Company. Zepbound Coverage and Savings. Zepbound.lilly.com
U.S. Food and Drug Administration. Human Drug Compounding and the FD&C Act. FDA.gov
National Association of Boards of Pharmacy. Compounding Pharmacy Accreditation Program. NABP.pharmacy
Texas State Board of Pharmacy. License Verification. pharmacy.texas.gov
Ro. Zepbound (Tirzepatide) Prescription Online for Weight Loss. Ro.co

Medical disclaimer: This content was researched and reviewed by the Luma Health medical team and is for informational purposes only. It does not constitute medical advice and should not replace consultation with a licensed healthcare provider. Pricing across this category changes frequently — verify current details directly with any provider mentioned before making a treatment decision. Luma Health's clinical services are provided by Wasef Health, PC. Compounded medications are prepared by VialsRX, a 503A community sterile compounding pharmacy licensed by the Texas State Board of Pharmacy (License #35264). Compounded preparations are not themselves FDA-approved as finished drug products; the active ingredients are FDA-approved in corresponding brand formulations. Eligibility for treatment is determined by a licensed clinician based on individual medical history. Individual results vary.